Clinical Trial Update: A First-in-Man Study of IBS [NA]

View source ↗

Summary

A first-in-man clinical trial of IBS conducted by Lifetech Scientific (Shenzhen) Co., Ltd. has completed in patients with single-vessel coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• IBS

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Single Coronary Vessel Disease | NA | Status: COMPLETED